Show simple item record

dc.contributor.authorNational Disease Surveillance Centre
dc.date.accessioned2013-10-08T08:43:43Z
dc.date.available2013-10-08T08:43:43Z
dc.date.issued2002
dc.identifier.urihttp://hdl.handle.net/10147/302960
dc.descriptionThis document is intended to give anoverview of the clinical management and public health implications of selected biological threat agents thought most likely to be used in terrorist attacks. The likelihood of such attacks were considered to be remote until the airliner attacks in the US on September 11th, 2001 and the mailing of finely milled anthrax spores to agencies and individuals in the US during October 2001. Systems for dealing with such incidents have been put in place by governments across the world in order to address the unlikely widespread use of such tactics by terrorist organisations. Early detection is essential for ensuring a prompt response to biological attacksen_GB
dc.language.isoenen
dc.publisherNational Disease Surveillance Centreen_GB
dc.subjectPOPULATION HEATLHen_GB
dc.subject.otherSECURITYen_GB
dc.subject.otherTERRORIST ATTACKen_GB
dc.titleBiological threat agentsen_GB
dc.typeReporten
refterms.dateFOA2018-08-23T08:12:20Z


Files in this item

Thumbnail
Name:
File603.pdf
Size:
542.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record